Early Versus Delayed Treatment with Ocrelizumab: A Multicenter, Real-World Observational Study in People with Multiple Sclerosis.

Alvarez E, Naismith RT, Hua LH, Pineda ED, Romdhani H, Guérin A, Lévesque-Leroux M, Marathe G, Nakamura K, Ontaneda D

Neurol Ther. 2026 May 30. PMID: 42217095. Abstract